Practices

Cases Investigated

Beasley Allen is currently investigating the following cases involving medical devices and drugs. However, our attorneys would like to investigate any claims of serious injury or death that may be the result of defective medical devices or drugs.

Extended use of talcum powder for female hygiene escalates risk of developing ovarian cancer

July 24, 2014 - Beasley Allen attorney Ted Meadows talks about the increased risk of developing ovarian cancer due to prolonged use of talcum powder. Read More




Testosterone replacement therapy lawsuits expected to climb into the thousands

June 26, 2014 - The lawsuits allege testosterone treatment makers withheld serious risks associated with the product while heavily marketing the therapy to consumers in an effort to drive profits. Read More


Lipitor and its risk of Type 2 diabetes explained by Beasley Allen attorney Frank Woodson

June 2, 2014 - Lipitor, known as the best-selling prescription drug ever, was approved by the Food and Drug Administration (FDA) in 1996. The drug's purpose was to help lower cholesterol; however, statin... Read More


Class action lawsuit links Johnson & Johnson baby powder to ovarian cancer risk

May 23, 2014 - Johnson & Johnson was hit with a class action lawsuit in California federal court over claims that its baby powder products significantly increase the risk of ovarian cancer when used by... Read More


Actos and its link to bladder cancer discussed by Beasley Allen attorney Andy Birchfield

May 20, 2014 - Actos, manufactured by Takeda Pharmaceuticals, was issued a warning by the FDA saying people who have been taking the drug for a year or longer have an increased risk of developing bladder... Read More


Actos, TVM and Zohydro litigation discussed by Andy Birchfield and Leigh O’Dell on Ringler Radio

May 19, 2014 - Beasley Allen attorneys Andy Birchfield and Leigh O'Dell discuss their progress on litigation involving Actos, Transvaginal Mesh and Zohydro. Read More


Federal jury orders drug makers Takeda, Eli Lilly to pay $9 billion for Actos cancer risk

April 8, 2014 - Jurors found Takeda Pharmaceutical Co. and Eli Lilly & Co. liable for a combined $9 billion in punitive damages after finding the drug makers hid cancer risks associated with Actos... Read More


Texas jury orders J&J to pay $1.2 million to woman injured by transvaginal mesh

April 4, 2014 - Jurors in a Dallas state court found Johnson & Johnson and its Ethicon unit liable for injuries caused by the design of its TVT-O mesh sling. Read More


Fields marked    may be required for submission.
  1. I'm an attorney
back to top